Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
[The guideline for the diagnosis and treatment of marginal zone lymphoma in China (2025)].
Аннотация на английскомСтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hematological Oncology Committee of China Anti-Cancer Association, Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association, Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO), Chinese Workshop of Indolent Lymphomas
Аннотация
Marginal zone lymphoma (MZL) is an indolent B-cell lymphoma arising from marginal zone B cells within lymphoid follicles, accounting for approximately 5%-15% of non-Hodgkin lymphomas. MZL is characterized by diagnostic challenges and diverse treatment options, making it a challenging subtype in clinical practice. In recent years, with the rapid progress in lymphoma research, the understanding of MZL has improved significantly worldwide. To further standardize the diagnosis and treatment of MZL in China, the Chinese Workshop of Indolent Lymphomas convened a panel of national experts. Based on thorough discussion and consensus, this guideline was developed to provide a reference for medical practitioners.